IL-6 antibodies
US10947309B2 · kind B2 · utility
0Cited by
36References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2015 |
| Grant date | Mar 16, 2021 |
| Priority date | — |
| Expiry date | Sep 25, 2037 |
Classification
- Technology area (CPC —)General
Abstract
Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6-related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.